Please Wait
Applying Filters...
menu
    • menu
    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.

    Virtual Booth

    Contact Supplier

    dmfs-not-supported-m-2025-05-19

    Virtual Booth

    An Enquiry

    Chirogate is a professional Prostaglandin manufacturer.

    Virtual Booth

    Contact Supplier

    Temad- We think of world-class quality.

    Virtual Booth

    Contact Supplier

    jdmfs-not-supported-m-2025-04-28

    Virtual Booth

    An Enquiry

    Menu

    Desvenlafaxine Succinate

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    ANALYTICAL

    PharmaCompass
    $ API Ref.Price (USD/KG) : 503Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 2ANGITA PHARMA INC.

    02 4APOTEX INC

    03 2JAMP PHARMA CORPORATION

    04 2PFIZER CANADA ULC

    05 2PRO DOC LIMITEE

    06 2SANDOZ CANADA INCORPORATED

    07 2SANIS HEALTH INC

    08 2TARO PHARMACEUTICALS INC

    09 2TEVA CANADA LIMITED

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    PharmaCompass
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    01

    APOTEX INC

    Canada
    STLE Annual Meeting
    Not Confirmed
    arrow

    APOTEX INC

    Canada
    arrow
    STLE Annual Meeting
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Canada
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : Prescription

    Registration Country : Canada

    DESVENLAFAXINE (DESVENLAFAXINE SUCCINATE)

    Brand Name : APO-DESVENLAFAXINE EXTENDED-RELEASE TABLETS

    Dosage Form : TABLET (EXTENDED-RELEASE)

    Dosage Strength : 50MG

    Packaging : 100

    Approval Date :

    Application Number : 2467119

    Regulatory Info : Prescription

    Registration Country : Canada

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    APOTEX INC

    Canada
    STLE Annual Meeting
    Not Confirmed
    arrow

    APOTEX INC

    Canada
    arrow
    STLE Annual Meeting
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Canada
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : Prescription

    Registration Country : Canada

    DESVENLAFAXINE (DESVENLAFAXINE SUCCINATE)

    Brand Name : APO-DESVENLAFAXINE EXTENDED-RELEASE TABLETS

    Dosage Form : TABLET (EXTENDED-RELEASE)

    Dosage Strength : 100MG

    Packaging :

    Approval Date :

    Application Number : 2467127

    Regulatory Info : Prescription

    Registration Country : Canada

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    03

    APOTEX INC

    Canada
    STLE Annual Meeting
    Not Confirmed
    arrow

    APOTEX INC

    Canada
    arrow
    STLE Annual Meeting
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Canada
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : Prescription

    Registration Country : Canada

    DESVENLAFAXINE

    Brand Name : APO-DESVENLAFAXINE

    Dosage Form : TABLET (EXTENDED-RELEASE)

    Dosage Strength : 50MG

    Packaging : 30/100/500

    Approval Date :

    Application Number : 2466988

    Regulatory Info : Prescription

    Registration Country : Canada

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    04

    APOTEX INC

    Canada
    STLE Annual Meeting
    Not Confirmed
    arrow

    APOTEX INC

    Canada
    arrow
    STLE Annual Meeting
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Canada
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : Prescription

    Registration Country : Canada

    DESVENLAFAXINE

    Brand Name : APO-DESVENLAFAXINE

    Dosage Form : TABLET (EXTENDED-RELEASE)

    Dosage Strength : 100MG

    Packaging : 30/100/500

    Approval Date :

    Application Number : 2466996

    Regulatory Info : Prescription

    Registration Country : Canada

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    05

    JAMP PHARMA CORPORATION

    Canada
    STLE Annual Meeting
    Not Confirmed
    arrow

    JAMP PHARMA CORPORATION

    Canada
    arrow
    STLE Annual Meeting
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Canada
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : Prescription

    Registration Country : Canada

    DESVENLAFAXINE (DESVENLAFAXINE SUCCINATE)

    Brand Name : JAMP DESVENLAFAXINE

    Dosage Form : TABLET (EXTENDED-RELEASE)

    Dosage Strength : 50MG

    Packaging : 90

    Approval Date :

    Application Number : 2495139

    Regulatory Info : Prescription

    Registration Country : Canada

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    06

    JAMP PHARMA CORPORATION

    Canada
    STLE Annual Meeting
    Not Confirmed
    arrow

    JAMP PHARMA CORPORATION

    Canada
    arrow
    STLE Annual Meeting
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Canada
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : Prescription

    Registration Country : Canada

    DESVENLAFAXINE (DESVENLAFAXINE SUCCINATE)

    Brand Name : JAMP DESVENLAFAXINE

    Dosage Form : TABLET (EXTENDED-RELEASE)

    Dosage Strength : 100MG

    Packaging : 90

    Approval Date :

    Application Number : 2495147

    Regulatory Info : Prescription

    Registration Country : Canada

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    07

    PFIZER CANADA ULC

    U.S.A
    STLE Annual Meeting
    Not Confirmed
    arrow

    PFIZER CANADA ULC

    U.S.A
    arrow
    STLE Annual Meeting
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : Prescription

    Registration Country : Canada

    DESVENLAFAXINE (DESVENLAFAXINE SUCCINATE)

    Brand Name : PRISTIQ

    Dosage Form : TABLET (EXTENDED-RELEASE)

    Dosage Strength : 50MG

    Packaging : 30/90

    Approval Date :

    Application Number : 2321092

    Regulatory Info : Prescription

    Registration Country : Canada

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    08

    PFIZER CANADA ULC

    U.S.A
    STLE Annual Meeting
    Not Confirmed
    arrow

    PFIZER CANADA ULC

    U.S.A
    arrow
    STLE Annual Meeting
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : Prescription

    Registration Country : Canada

    DESVENLAFAXINE (DESVENLAFAXINE SUCCINATE)

    Brand Name : PRISTIQ

    Dosage Form : TABLET (EXTENDED-RELEASE)

    Dosage Strength : 100MG

    Packaging : 30/90

    Approval Date :

    Application Number : 2321106

    Regulatory Info : Prescription

    Registration Country : Canada

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    09

    TEVA CANADA LIMITED

    Israel
    STLE Annual Meeting
    Not Confirmed
    arrow

    TEVA CANADA LIMITED

    Israel
    arrow
    STLE Annual Meeting
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Israel
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : Prescription

    Registration Country : Canada

    DESVENLAFAXINE (DESVENLAFAXINE SUCCINATE)

    Brand Name : TEVA-DESVENLAFAXINE

    Dosage Form : TABLET (EXTENDED-RELEASE)

    Dosage Strength : 100MG

    Packaging : 30/100

    Approval Date :

    Application Number : 2458225

    Regulatory Info : Prescription

    Registration Country : Canada

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    10

    TEVA CANADA LIMITED

    Israel
    STLE Annual Meeting
    Not Confirmed
    arrow

    TEVA CANADA LIMITED

    Israel
    arrow
    STLE Annual Meeting
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Israel
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : Prescription

    Registration Country : Canada

    DESVENLAFAXINE (DESVENLAFAXINE SUCCINATE)

    Brand Name : TEVA-DESVENLAFAXINE

    Dosage Form : TABLET (EXTENDED-RELEASE)

    Dosage Strength : 50MG

    Packaging : 30/100

    Approval Date :

    Application Number : 2458217

    Regulatory Info : Prescription

    Registration Country : Canada

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF